342 related articles for article (PubMed ID: 31916060)
21. Combined effects of genetic and non-genetic risk factors affect response to ranibizumab in exudative age-related macular degeneration.
Piermarocchi S; Miotto S; Colavito D; Leon A; Segato T
Acta Ophthalmol; 2015 Sep; 93(6):e451-7. PubMed ID: 25402348
[TBL] [Abstract][Full Text] [Related]
22. Factors Associated with Recurrence of Age-Related Macular Degeneration after Anti-Vascular Endothelial Growth Factor Treatment: A Retrospective Cohort Study.
Kuroda Y; Yamashiro K; Miyake M; Yoshikawa M; Nakanishi H; Oishi A; Tamura H; Ooto S; Tsujikawa A; Yoshimura N
Ophthalmology; 2015 Nov; 122(11):2303-10. PubMed ID: 26271842
[TBL] [Abstract][Full Text] [Related]
23. The association of exudation pattern with anatomical and functional outcomes in patients with Neovascular Age-Related Macular Degeneration.
Inan S; Polat O; Karadas M; Inan UU
Rom J Ophthalmol; 2019; 63(3):238-244. PubMed ID: 31687625
[No Abstract] [Full Text] [Related]
24. Evaluation of CC-cytokine ligand 2 and complementary factor H Y402H polymorphisms and their interactional association with age-related macular degeneration.
Bonyadi M; Foruzandeh Z; Mohammadian T; Fotouhi N; Soheilian M; Jabbarpoor Bonyadi MH; Javadzadeh A; Moein H; Yaseri M
Acta Ophthalmol; 2016 Dec; 94(8):e779-e785. PubMed ID: 27316788
[TBL] [Abstract][Full Text] [Related]
25. Association of complement factor H and LOC387715 genotypes with response of exudative age-related macular degeneration to intravitreal bevacizumab.
Brantley MA; Fang AM; King JM; Tewari A; Kymes SM; Shiels A
Ophthalmology; 2007 Dec; 114(12):2168-73. PubMed ID: 18054635
[TBL] [Abstract][Full Text] [Related]
26. Predictors of Response to Intravitreal Anti-Vascular Endothelial Growth Factor Treatment of Age-Related Macular Degeneration.
Shah AR; Williams S; Baumal CR; Rosner B; Duker JS; Seddon JM
Am J Ophthalmol; 2016 Mar; 163():154-166.e8. PubMed ID: 26705092
[TBL] [Abstract][Full Text] [Related]
27. CFH, VEGF and HTRA1 promoter genotype may influence the response to intravitreal ranibizumab therapy for neovascular age-related macular degeneration.
McKibbin M; Ali M; Bansal S; Baxter PD; West K; Williams G; Cassidy F; Inglehearn CF
Br J Ophthalmol; 2012 Feb; 96(2):208-12. PubMed ID: 21558292
[TBL] [Abstract][Full Text] [Related]
28. Polymorphisms in vascular endothelial growth factor receptor 2 are associated with better response rates to ranibizumab treatment in age-related macular degeneration.
Hermann MM; van Asten F; Muether PS; Smailhodzic D; Lichtner P; Hoyng CB; Kirchhof B; Grefkes C; den Hollander AI; Fauser S
Ophthalmology; 2014 Apr; 121(4):905-10. PubMed ID: 24365177
[TBL] [Abstract][Full Text] [Related]
29. Three major loci involved in age-related macular degeneration are also associated with polypoidal choroidal vasculopathy.
Lima LH; Schubert C; Ferrara DC; Merriam JE; Imamura Y; Freund KB; Spaide RF; Yannuzzi LA; Allikmets R
Ophthalmology; 2010 Aug; 117(8):1567-70. PubMed ID: 20378180
[TBL] [Abstract][Full Text] [Related]
30. Association of the Complement Factor H Y402H Polymorphism and Response to Anti-Vascular Endothelial Growth Factor Treatment in Age-Related Macular Degeneration: An Updated Meta-Analysis.
Roshanshad A; Moosavi SA; Arevalo JF
Ophthalmic Res; 2024; 67(1):358-386. PubMed ID: 38754401
[TBL] [Abstract][Full Text] [Related]
31. The ARMS2 A69S Polymorphism Is Associated with Delayed Rod-Mediated Dark Adaptation in Eyes at Risk for Incident Age-Related Macular Degeneration.
Mullins RF; McGwin G; Searcey K; Clark ME; Kennedy EL; Curcio CA; Stone EM; Owsley C
Ophthalmology; 2019 Apr; 126(4):591-600. PubMed ID: 30389424
[TBL] [Abstract][Full Text] [Related]
32. Pharmacogenetic associations with vascular endothelial growth factor inhibition in participants with neovascular age-related macular degeneration in the IVAN Study.
Lotery AJ; Gibson J; Cree AJ; Downes SM; Harding SP; Rogers CA; Reeves BC; Ennis S; Chakravarthy U;
Ophthalmology; 2013 Dec; 120(12):2637-2643. PubMed ID: 24070809
[TBL] [Abstract][Full Text] [Related]
33. Retinal Pigment Epithelial Atrophy in Neovascular Age-Related Macular Degeneration After Ranibizumab Treatment.
Kuroda Y; Yamashiro K; Tsujikawa A; Ooto S; Tamura H; Oishi A; Nakanishi H; Miyake M; Yoshikawa M; Yoshimura N
Am J Ophthalmol; 2016 Jan; 161():94-103.e1. PubMed ID: 26432927
[TBL] [Abstract][Full Text] [Related]
34. CFH haplotypes and ARMS2, C2, C3, and CFB alleles show association with susceptibility to age-related macular degeneration in Mexicans.
Contreras AV; Zenteno JC; Fernández-López JC; Rodríguez-Corona U; Falfán-Valencia R; Sebastian L; Morales F; Ochoa-Contreras D; Carnevale A; Silva-Zolezzi I
Mol Vis; 2014; 20():105-16. PubMed ID: 24453474
[TBL] [Abstract][Full Text] [Related]
35. Suggestive association between PLA2G12A single nucleotide polymorphism rs2285714 and response to anti-vascular endothelial growth factor therapy in patients with exudative age-related macular degeneration.
Wang VM; Rosen RB; Meyerle CB; Kurup SK; Ardeljan D; Agron E; Tai K; Pomykala M; Chew EY; Chan CC; Tuo J
Mol Vis; 2012; 18():2578-85. PubMed ID: 23112570
[TBL] [Abstract][Full Text] [Related]
36. CFH Y402H polymorphism and response to intravitreal ranibizumab in Brazilian patients with neovascular age-related macular degeneration.
Veloso CE; Almeida LN; Nehemy MB
Rev Col Bras Cir; 2014; 41(6):386-92. PubMed ID: 25742403
[TBL] [Abstract][Full Text] [Related]
37. VEGFR2 Gene Polymorphisms and Response to Anti-Vascular Endothelial Growth Factor Therapy in Age-Related Macular Degeneration.
Hagstrom SA; Ying GS; Maguire MG; Martin DF; ; Gibson J; Lotery A; Chakravarthy U;
Ophthalmology; 2015 Aug; 122(8):1563-8. PubMed ID: 26028346
[TBL] [Abstract][Full Text] [Related]
38. Variants in the VEGFA gene and treatment outcome after anti-VEGF treatment for neovascular age-related macular degeneration.
Abedi F; Wickremasinghe S; Richardson AJ; Makalic E; Schmidt DF; Sandhu SS; Baird PN; Guymer RH
Ophthalmology; 2013 Jan; 120(1):115-21. PubMed ID: 23149126
[TBL] [Abstract][Full Text] [Related]
39. Initial exploration of oral pazopanib in healthy participants and patients with age-related macular degeneration.
McLaughlin MM; Paglione MG; Slakter J; Tolentino M; Ye L; Xu CF; Suttle AB; Kim RY
JAMA Ophthalmol; 2013 Dec; 131(12):1595-601. PubMed ID: 24113783
[TBL] [Abstract][Full Text] [Related]
40. Genetic and clinical factors associated with reticular pseudodrusen in exudative age-related macular degeneration.
Yoneyama S; Sakurada Y; Mabuchi F; Imasawa M; Sugiyama A; Kubota T; Iijima H
Graefes Arch Clin Exp Ophthalmol; 2014 Sep; 252(9):1435-41. PubMed ID: 24595987
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
